| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |